A medication developed in the 1950s to treat Parkinson's disease may offer a powerful new tool in the fight against tuberculosis (TB), according to new research from the University of British Columbia ...

The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...

Analysis of finger sweat detected isoniazid in adults with tuberculosis (TB) for ≤ 6 hours after administration, based on data from a new pilot study. Risk factors for TB treatment failure include ...

Authored by - Chapal Mehra, public health specialist, New Delhi and Zarir Udwadia, consultant physician, Hinduja and Breach ...

SAFARI is a biodegradable gelatin or cellulose pill casing with a radiofrequency chip that sends a signal confirming ...

Patient choice in taking treatment is framed by the physiological and psychological impacts of the disease and also by the social and cultural structures in which the person is immersed. [68] Patient ...

Antimicrobial stewardship (AMS) refers to coordinated strategies for the targeted, evidence-based, and safe use of ...

Tufts University researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures Tuberculosis (TB) is the world’s deadliest infectious disease—and ...

The approval significantly strengthens Delhi’s ability to diagnose multidrug-resistant (MDR-TB) and drug-resistant ...

A person with HIV may be more at risk of developing tuberculosis (TB). This is due to the weakening of the immune system that occurs in someone who has HIV. Tuberculosis (TB) is a bacterial infection ...